{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T16:52:15Z","timestamp":1791478335829,"version":"4.3.4"},"reference-count":22,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:00:00Z","timestamp":1775692800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004336","name":"Novartis AG","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology, Transfusion and Cell Therapy"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.htct.2026.106459","type":"journal-article","created":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T21:59:10Z","timestamp":1777327150000},"page":"106459","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluating the treatment of patients with paroxysmal nocturnal hemoglobinuria in Brazil: disparities in access and treatment persistence"],"prefix":"10.1016","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3269-3780","authenticated-orcid":false,"given":"Rodolfo Delfini","family":"Can\u00e7ado","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2971-7203","authenticated-orcid":false,"given":"Paula","family":"de Melo Campos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7275-6358","authenticated-orcid":false,"given":"Diego","family":"Kashiura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-9258-7368","authenticated-orcid":false,"given":"Felipe","family":"Thies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-0985-5664","authenticated-orcid":false,"given":"Erica","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9111-1360","authenticated-orcid":false,"given":"Ana Beatriz Machado","family":"de Almeida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1529-0488","authenticated-orcid":false,"given":"Lays Paulino","family":"Leonel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7762-1997","authenticated-orcid":false,"given":"Lucas Vieira","family":"Cortez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7951-1019","authenticated-orcid":false,"given":"Nina","family":"Melo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-2995-2446","authenticated-orcid":false,"given":"Fabio","family":"Fedozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2483-3299","authenticated-orcid":false,"given":"Alessandro","family":"Bigoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.htct.2026.106459_bib0001","article-title":"Paroxysmal nocturnal haemoglobinuria","volume":"3","author":"Hill","year":"2017","journal-title":"Nat Rev Dis Primers [Internet]"},{"issue":"12","key":"10.1016\/j.htct.2026.106459_bib0002","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.1182\/blood-2005-04-1717","article-title":"Diagnosis and management of paroxysmal nocturnal hemoglobinuria","volume":"106","author":"Parker","year":"2005","journal-title":"Blood [Internet]"},{"key":"10.1016\/j.htct.2026.106459_bib0003","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/978-90-481-9485-8_22","article-title":"Epidemiology of rare anaemias in europe","volume":"686","author":"Vives Corrons","year":"2010","journal-title":"Adv Exp Med Biol [Internet]"},{"key":"10.1016\/j.htct.2026.106459_bib0004","article-title":"Laboratory studies for paroxysmal nocturnal hemoglobinuria, with emphasis on flow cytometry","volume":"20","author":"Lima","year":"2020","journal-title":"Pract Lab Med [Internet]"},{"issue":"1","key":"10.1016\/j.htct.2026.106459_bib0005","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1182\/asheducation-2016.1.208","article-title":"Update on the diagnosis and management of paroxysmal nocturnal hemoglobinuria","volume":"2016","author":"Parker","year":"2016","journal-title":"Hematology [Internet]"},{"issue":"2","key":"10.1016\/j.htct.2026.106459_bib0006","first-page":"74","article-title":"The Advancing Landscape of Paroxysmal Nocturnal Hemoglobinuria Treatment","volume":"42","author":"Perry","year":"2025","journal-title":"Turkish Journal of Hematology [Internet]"},{"issue":"2","key":"10.1016\/j.htct.2026.106459_bib0007","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/bjh.15790","article-title":"Eculizumab in paroxysmal nocturnal haemoglobinuria and atypical haemolytic uraemic syndrome: 10-year pharmacovigilance analysis","volume":"185","author":"Soci\u00e9","year":"2019","journal-title":"Br J Haematol [Internet]"},{"key":"10.1016\/j.htct.2026.106459_bib0008","unstructured":"BRASIL. PORTARIA No 618, DE 16 DE SETEMBRO DE 2022. 2022."},{"key":"10.1016\/j.htct.2026.106459_bib0009","unstructured":"BRASIL. \u201cProtocolos Cl\u00ednicos e Diretrizes Terap\u00eauticas Hemoglobin\u00faria Parox\u00edstica Noturna.\u201d 2019."},{"key":"10.1016\/j.htct.2026.106459_bib0010","unstructured":"BRASIL. Recommendation Report: Ravulizumab in the treatment of Paroxysmal Nocturnal Hemoglobinuria. 2024."},{"issue":"1","key":"10.1016\/j.htct.2026.106459_bib0011","first-page":"1","article-title":"Coverage and equity in reproductive and maternal health interventions in Brazil: Impressive progress following the implementation of the Unified Health System","volume":"15","author":"Fran\u00e7a","year":"2016","journal-title":"Int J Equity Health [Internet]"},{"key":"10.1016\/j.htct.2026.106459_bib0012","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2022.1065742","article-title":"Estimation method for distance cost to access medical services: policy and patient privacy implications in Taiwan","volume":"10","author":"Guo","year":"2022","journal-title":"Front Public Health"},{"key":"10.1016\/j.htct.2026.106459_bib0013","unstructured":"[T\u00edtulo em Portugu\u00eas gerado por IA] V\u00ednculo De Registros De Sa\u00fade Brasileiro (BRHC-RLK) \u2013 Uma Metodologia De V\u00ednculo De Registros Para Conjuntos De Dados De Reclama\u00e7\u00f5es M\u00e9dicas Brasileiros (DATASUS) | Brazilian Healthcare Record Linkage (BRHC-RLK): A Record Linkage Methodology For Brazilian Medical Claims Datasets (DATASUS) [Internet]. [cited 2025]. Available from: https:\/\/htadata.com\/2017ispor168\/"},{"issue":"4","key":"10.1016\/j.htct.2026.106459_bib0014","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.htct.2023.12.004","article-title":"Epidemiology, patient journey and unmet needs related to hemophilia in Brazil: a scoping review with evidence map","volume":"46","author":"Schneider","year":"2024","journal-title":"Hematol Transfus Cell Ther [Internet]"},{"issue":"2","key":"10.1016\/j.htct.2026.106459_bib0015","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1590\/S0103-21002012000200008","article-title":"Dificuldades para enfrentar sozinho as demandas do tratamento: viv\u00eancias do adolescente hemof\u00edlico","volume":"25","author":"Vrabic","year":"2012","journal-title":"Acta Paulista de Enfermagem [Internet]"},{"issue":"8","key":"10.1016\/j.htct.2026.106459_bib0016","doi-asserted-by":"crossref","first-page":"4461","DOI":"10.1007\/s12325-021-01825-4","article-title":"Real-world healthcare resource utilization (HRU) and costs of patients with paroxysmal nocturnal hemoglobinuria (PNH) receiving eculizumab in a US Population","volume":"38","author":"Cheng","year":"2021","journal-title":"Adv Ther [Internet]"},{"issue":"10","key":"10.1016\/j.htct.2026.106459_bib0017","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1007\/s00417-020-04798-2","article-title":"Systematic review: non-adherence and non-persistence in intravitreal treatment","volume":"258","author":"Ehlken","year":"2020","journal-title":"Graefe\u2019s Archive for Clinical and Experimental Ophthalmology [Internet]"},{"issue":"9 September","key":"10.1016\/j.htct.2026.106459_bib0018","article-title":"Patient preferences and quality of life implications of ravulizumab (every 8 weeks) and eculizumab (every 2 weeks) for the treatment of paroxysmal nocturnal hemoglobinuria","volume":"15","author":"Peipert","year":"2020","journal-title":"PLoS One [Internet]"},{"issue":"3","key":"10.1016\/j.htct.2026.106459_bib0019","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1053\/j.seminhematol.2018.02.002","article-title":"Expanding complement therapeutics for the treatment of paroxysmal nocturnal hemoglobinuria","volume":"55","author":"Mastellos","year":"2018","journal-title":"Semin Hematol[Internet]"},{"issue":"4","key":"10.1016\/j.htct.2026.106459_bib0020","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/ejh.13816","article-title":"The burden of illness of patients with paroxysmal nocturnal haemoglobinuria receiving C5 inhibitors in France, Germany and the United Kingdom: Patient-reported insights on symptoms and quality of life","volume":"109","author":"Panse","year":"2022","journal-title":"Eur J Haematol [Internet]"},{"issue":"7 JULY","key":"10.1016\/j.htct.2026.106459_bib0021","article-title":"Characteristics of paroxysmal nocturnal hemoglobinuria patients in Brazil: A retrospective administrative claims database analysis of PNH patients in Brazilian public healthcare system","volume":"18","author":"Gualandro","year":"2023","journal-title":"PLoS One [Internet]"},{"issue":"3","key":"10.1016\/j.htct.2026.106459_bib0022","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1007\/s12029-020-00508-7","article-title":"Epidemiological and clinical patterns of newly diagnosed hepatocellular carcinoma in Brazil: the need for liver disease screening programs based on real-world data","volume":"52","author":"Fernandes G dos","year":"2021","journal-title":"J Gastrointest Cancer [Internet]"}],"container-title":["Hematology, Transfusion and Cell Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2531137926002063?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2531137926002063?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T16:03:08Z","timestamp":1791475388000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2531137926002063"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S2531137926002063"],"URL":"https:\/\/doi.org\/10.1016\/j.htct.2026.106459","relation":{},"ISSN":["2531-1379"],"issn-type":[{"value":"2531-1379","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluating the treatment of patients with paroxysmal nocturnal hemoglobinuria in Brazil: disparities in access and treatment persistence","name":"articletitle","label":"Article Title"},{"value":"Hematology, Transfusion and Cell Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.htct.2026.106459","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Associa\u00e7\u00e3o Brasileira de Hematologia, Hemoterapia e Terapia Celular. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"106459"}}